Tuesday, 30 June 2009

Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015

So, no chance at all of the pharmaceutical industry promoting Low Dose Naltrexone (LDN) it would seem.


Thursday, 25 June 2009

Sunday, 21 June 2009

US Democrats Produce Draft Plan for Universal Health Insurance


This story documents what could be the start of a long, long journey for the US towards the sort of Universal Health Care Coverage that it's citizens need and deserve.

Saturday, 20 June 2009

Immune Response Stimulating Drug Found to Reduce Prostate Tumour Size

Preliminary findings show that ' ipilimumab' shrinks prostrate tumours to operable size.

Wednesday, 17 June 2009

New Yahoo! Group for Low Dose Naltrexone (LDN) Users who Have IBD (Inflammatory Bowel Disease)

A new Yahoo! Groups group which is specifically aimed at those who take, or are interested in taking Low Dose Naltrexone (LDN) for IBD (Inflammatory Bowel Disease), e.g. Crohn's Disease and Ulcerative Colitis.


A New Low Dose Naltrexone (LDN) Petition for Australia

http://www.gopetiti on.com/online/ 28354.html

National Health Funding for Low Dose Naltrexone in Australia

Published by Trevor George Stephens
Date: Jun 06, 2009
Category: Health
Region: Australia
Target: Cancer sufferers MS sufferers and HIV+ persons
Web site: http://www.lowdosen altrexone. org/

Background (Preamble):

I was diagnosed as being HIV+ in 1987: I participated in the Ozone trial in
the Philippines in 1993 while practicing various alternative and natural
therapies and am 60 years of age in Sept. 2009 and am healthy and well.

I pursued further Ozone treatment in 1999 in Kenya with the scientist who
developed that particular method of delivery called Polyatomic Apheresis -
The late Basil Wainwright - and returned to Australia early 2000. I
discovered in that year a seeming decrease in my CD4 cells and a
concomitant decrease in my platelets so I went on medication then and
remained fairly steadily on it for some time - four years -with a couple of
intermittent breaks from it due to the development of small lumps in my
sides (abdominal area). In all of this time my cd4's have been only between
200 and 300: however, after being on LDN for some three months - from round
September 2008 - they showed the most significant increase I have seen
since the Ozone trial in 1993.....CD4' s were 350 and CD8's were 1096 with a
non detectable viral load.

I had a few weeks off around the Christmas and have now passed another
three/four month period taking 4.5 mg every night. My latest results at May
2009 are ... non detectable viral load and CD4 count of 293. The present
cost of this medication at the lower end of the scale is $100+.00 every
three months. I am receipt of a disability pension. I have an interest in
drawing official attention to this medication and having it listed on the
pharmaceutical benefits listings.

Please send this on to anyone within serious immune boosting concerns /
view the LDN site and sign the petition. Return this petition to me on the
20th January 2010 for review.

Click 'Tell' to send this petition on and you will assist in maintaining
its momentum and growth.

We petition the Australian government to make funds available for trials
and research for LDN to achieve a licence and public availability. This
medication must be added to the pharmaceuticals benefits listings.

We petition the Australian government to make funding available, either
directly through taxes or indirectly by directing research bodies to
provide funding, to undergo trials for the generic drug, Low Dose
Naltrexone (LDN).

Primarily this is to be done for Cancer since there lies the biggest
savings of life and economy, but then also for the many other diseases,
such as MS, Crohns disease, Fibromyalgia, Rheumatoid Arthritis, HIV/Aids
and many more.

Alternatively, the drug should be made available on the basis of it's
widespread use and the widespread positive reports of the many doctors
around the world who are currently using it. The evidence about this drug
has overtaken the trials process already and as such, we ask also that this
drug be made available as front line treatment, now. The research should
then be performed to confirm the drug and resolve the many unanswered
questions surrounding it.

To sumarise, we ask for the funding to be provided and the drug to be made
freely available to those who request it. The drug has been proven safe at
high dose usage so the safety trials are done, and we know of no drugs
which become unsafe at low dose when safe at high ones. In 25 years, the
drug industry has ignored this drug due to lack of return on investment, so
we believe that only government led intervention can break this scandalous
apathy. LDN now, save our sick, save our economy.

Please fund LDN Now!

To sign the petition:
http://www.gopetiti on.com/online/ 28354.html

Crohn's Disease Put into Remission in Children with Supplemental Nutrition Alone

This article relates how researchers have used nutritional supplements developed by NASA to induce remission in children which is as effective as steroids without any of the side-effects.


Sunday, 14 June 2009

LOw-Dose Naltrexone for Fibromyalgia & Chronic Fatigue Syndrome

"An exciting thing about LDN is that it's inexpensive and already on the market. Anecdotal evidence so far is very promising, as is the first clinical trial for FMS."

Friday, 12 June 2009

Low Dose Naltrexone : The Next Miracle Drug?

by Michael D. Shaw, Exec VP, Interscan Corporation

"LDN is inexpensive with virtually no harmful side effects. However, since it is no longer a proprietary drug, the pace of rolling out clinical trials for the off-label effects described in this article will probably be slow, as will its acceptance by mainstream medicine. Still, there is nothing to prevent a patient from taking an FDA approved drug for an off-label indication, and this practice goes on all the time.

Certainly, there is much appeal in a naturally-acting immune modulator that is cheap and effective. We await the publication of further results."

Tuesday, 9 June 2009

UK Low Dose Naltrexone (LDN) NHS Trial Petition Surpasses 2,500 Signatures

The petition on the UK Number 10 Government petition web site to request a Low Dose Naltrexone (LDN) NHS-funded clinical trial
has now surpassed 2,500 signatures.

In order to be seriously considered by the UK government, this petition will need to reach 15,000 signatures by 23rd November this year.

If you are a UK citizen, or know one, please spread the word about this important petition.
If you have already signed it, please pass it on to anyone you know who can sign and please ask them to do the same.

The election of the BNP to the European Parliament demonstrates, albeit in an unpleasant way, how a small number of people can
instigate change - Please use your power to help this petition change the way that Low Dose Naltrexone (LDN) is used in the UK
National Health Service and help the millions of people who could benefit from access to this drug move a step closer to the 
opportunity to gain relief from their daily suffering.

Thank you.

Thursday, 4 June 2009

MS Patient Blog - Improvement Continuing Using Low Dose Naltrexone (LDN)

Julie Stachowiak, Ph.D., writing in her about.com blog - She continues to show improvement in her Multiple Sclerosis symptoms due to treatment with Low Dose Naltrexone (LDN) -